Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty
- Conditions
- Osteoarthritis, Hip
- Interventions
- Drug: Standard of CareDrug: Multi-modal with as needed opioidsDrug: Multi-modal with one week of opioids offered
- Registration Number
- NCT03358888
- Lead Sponsor
- Rothman Institute Orthopaedics
- Brief Summary
This is a prospective, three-arm, comparative study with a provider-crossover design. The first arm will comprise the standard of care pain regimen after discharge, which comprises PRN oxycodone, tramadol, and acetaminophen. The second arm will comprise a multimodal pain regimen; however, patients will still be routinely provided PRN oxycodone and tramadol to use on an as needed basis. The third arm will comprise a multimodal pain management protocol, which does not routinely allow for opioid consumption. However, patients will be provided a one week supply of oxycodone and tramadol for emergency pain relief only.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 228
- Patients undergoing unilateral, primary cementless THA with underlying diagnosis of osteoarthritis.
- ASA I - III
- Spinal anesthesia
- Male and Female over 18 who are willing and able to provide informed consent
- Opioid use within 3 months prior to surgery
- General anesthesia
- Non-english speaking
- ASA IV or greater
- Allergy/contraindications to protocol medications
- Renal insufficiency with Cr > 2.0 or hepatic failure
- Sensory/motor disorder involving the operative limb
- Planned or unplanned discharge to rehab
- Length of stay >3 days
- Revision or conversion THA
- Cigarette smokers
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Standard of Care Standard of Care - Multi-modal with as needed opioids Multi-modal with as needed opioids - Multi-modal with one week of opioids offered Multi-modal with one week of opioids offered -
- Primary Outcome Measures
Name Time Method Pain 30 days post-operative Pain as reported by Visual Analog Scale
total opioid consumption total consumption calcuated from surgery date through 30 days post-op
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Rothman Institute
🇺🇸Philadelphia, Pennsylvania, United States